[Urticaria and angioedema].
Miyachi
Y
Y
Department of Dermatology, Kyoto University Graduate School of Medicine.
D000799:Angioedema / Q000145:classification / Q000209:etiology; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D001323:Autoantibodies; D003174:Complement C1 Inactivator Proteins / Q000008:administration & dosage / Q000172:deficiency / Q000276:immunology; D003937:Diagnosis, Differential; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E; D008407:Mast Cells / Q000276:immunology; D011379:Prognosis; D017455:Receptors, IgE / Q000276:immunology; D045165:Testosterone Congeners / Q000627:therapeutic use; D014581:Urticaria / Q000145:classification / Q000209:etiology; D014777:Virus Diseases / Q000150:complications
D018926:Anti-Allergic Agents; D001323:Autoantibodies; D003174:Complement C1 Inactivator Proteins; D006634:Histamine H1 Antagonists; D017455:Receptors, IgE; D045165:Testosterone Congeners; D007073:Immunoglobulin E